chr11-56469720-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001004742.3(OR5M3):c.778C>T(p.Arg260Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000775 in 1,611,904 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004742.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5M3 | NM_001004742.3 | c.778C>T | p.Arg260Cys | missense_variant | 2/2 | ENST00000641993.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5M3 | ENST00000641993.1 | c.778C>T | p.Arg260Cys | missense_variant | 2/2 | NM_001004742.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152048Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000844 AC: 21AN: 248780Hom.: 0 AF XY: 0.0000966 AC XY: 13AN XY: 134540
GnomAD4 exome AF: 0.0000822 AC: 120AN: 1459740Hom.: 1 Cov.: 30 AF XY: 0.0000799 AC XY: 58AN XY: 726208
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152164Hom.: 1 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.778C>T (p.R260C) alteration is located in exon 1 (coding exon 1) of the OR5M3 gene. This alteration results from a C to T substitution at nucleotide position 778, causing the arginine (R) at amino acid position 260 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at